Noven Pharmaceuticals Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 610

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

  • Investments
  • 4

Noven Pharmaceuticals General Information

Description

Manufacturer of prescription pharmaceutical products intended for patient care through transdermal drug delivery. The company is primarily focused on the areas of women's health and mental health, including ADHD and schizophrenia.

Contact Information

Website
www.noven.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 11960 South West
  • 144th Street
  • Miami, FL 33186
  • United States
+1 (305)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • 11960 South West
  • 144th Street
  • Miami, FL 33186
  • United States
+1 (305)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Noven Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Noven Pharmaceuticals‘s full profile, request access.

Request a free trial

Noven Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of prescription pharmaceutical products intended for patient care through transdermal drug delivery. The co
Pharmaceuticals
Miami, FL
610 As of 2008

Mississauga, Canada
 

Mississauga, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Noven Pharmaceuticals Competitors (22)

One of Noven Pharmaceuticals’s 22 competitors is Acerus Pharmaceuticals, a Corporation company based in Mississauga, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Acerus Pharmaceuticals Corporation Mississauga, Canada
Cipher Pharmaceuticals Formerly PE-Backed Mississauga, Canada
Tris Pharma Private Debt Financed Monmouth Junction, NJ
Novartis Corporation Basel, Switzerland
GSK Corporation London, United Kingdom
You’re viewing 5 of 22 competitors. Get the full list »

Noven Pharmaceuticals Patents

Noven Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3203042-A1 Amphetamine carbamate compounds and methods Pending 07-Jan-2021
EP-4275055-A2 Amphetamine carbamate compounds and methods Pending 07-Jan-2021
US-11572339-B2 Amphetamine carbamate compounds and methods Active 07-Jan-2021
US-11976026-B2 Amphetamine carbamate compounds and methods Active 07-Jan-2021
US-20220213029-A1 Amphetamine carbamate compounds and methods Active 07-Jan-2021 C07C269/08
To view Noven Pharmaceuticals’s complete patent history, request access »

Noven Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Noven Pharmaceuticals Investments & Acquisitions (4)

Noven Pharmaceuticals’s most recent deal was a Merger/Acquisition with JDS Pharmaceuticals for . The deal was made on 14-Aug-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
JDS Pharmaceuticals 14-Aug-2007 Merger/Acquisition Pharmaceuticals
Salient Surgical Technologies 20-Mar-2007 Later Stage VC Surgical Devices
Salient Surgical Technologies 31-Jan-2003 Later Stage VC Surgical Devices
Salient Surgical Technologies 15-Jan-2002 Later Stage VC Surgical Devices
To view Noven Pharmaceuticals’s complete investments and acquisitions history, request access »

Noven Pharmaceuticals Exits (3)

Noven Pharmaceuticals’s most recent exit was on 20-Mar-2007 from Salient Surgical Technologies. The exit was categorized as with 10 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Salient Surgical Technologies 20-Mar-2007 Completed
  • 10 buyers
Salient Surgical Technologies 31-Jan-2003 Completed
  • 9 buyers
Salient Surgical Technologies 15-Jan-2002 Later Stage VC Completed
  • 14 buyers
To view Noven Pharmaceuticals’s complete exits history, request access »

Noven Pharmaceuticals FAQs

  • When was Noven Pharmaceuticals founded?

    Noven Pharmaceuticals was founded in 1987.

  • Where is Noven Pharmaceuticals headquartered?

    Noven Pharmaceuticals is headquartered in Miami, FL.

  • What is the size of Noven Pharmaceuticals?

    Noven Pharmaceuticals has 610 total employees.

  • What industry is Noven Pharmaceuticals in?

    Noven Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Noven Pharmaceuticals a private or public company?

    Noven Pharmaceuticals is a Private company.

  • What is the current valuation of Noven Pharmaceuticals?

    The current valuation of Noven Pharmaceuticals is .

  • What is Noven Pharmaceuticals’s current revenue?

    The current revenue for Noven Pharmaceuticals is .

  • Who are Noven Pharmaceuticals’s competitors?

    Acerus Pharmaceuticals, Cipher Pharmaceuticals, Tris Pharma, Novartis, and GSK are some of the 22 competitors of Noven Pharmaceuticals.

  • When was Noven Pharmaceuticals acquired?

    Noven Pharmaceuticals was acquired on 27-Aug-2009.

  • Who acquired Noven Pharmaceuticals?

    Noven Pharmaceuticals was acquired by Hisamitsu Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »